Deregulated Nutrient Sensing

Four interlinked pathways sense nutrient and energy availability and translate it into growth, storage, or conservation programs: insulin/IGF-1 signaling (IIS), mTOR, AMPK, and sirtuins. Reduced IIS is the most consistently reproduced lifespan-extension finding in invertebrate biology; loss-of-function mutations in the daf-2 insulin/IGF-1 receptor gene in C. elegans roughly double lifespan, and equivalent IGF-1 receptor mutations extend lifespan in mice, though effect sizes shrink considerably moving from worms to mammals [1].

In humans, a well-studied cohort of Ashkenazi Jewish centenarians carries a higher frequency of IGF-1 receptor mutations that reduce receptor function, and centenarian offspring have measurably different IGF-1 signaling profiles than age-matched controls without a centenarian parent, observational evidence consistent with the animal findings but not proof of causation in humans [1][2]. Caloric restriction, the most consistently replicated experimental intervention across all four pathways simultaneously, extends lifespan reliably in rodents and non-human primates in some but not all long-term primate studies, and the two-year CALERIE randomized trial of roughly 12% caloric restriction in non-obese adults found improved insulin sensitivity, blood pressure, and lipid markers relative to controls without a mortality endpoint, since the trial was not powered or long enough to measure lifespan [4].

What the evidence does not show: no human RCT has tested lifelong caloric restriction or pharmacological nutrient-sensing modulation against a mortality endpoint, for practical and ethical reasons, so human data rests on shorter biomarker trials and observational centenarian genetics. Reduced IGF-1 signaling in humans is also associated with increased frailty and reduced muscle mass in some elderly populations, complicating a simple "lower is better" interpretation outside of specific genetic contexts [2].

Blueprint's approach to nutrient sensing centers on time-restricted eating and a calorie-controlled, nutrient-dense diet (roughly 1,977 calories per day as previously reported by Bryan Johnson), an n=1 implementation of caloric restriction principles rather than a controlled comparison against ad libitum eating [3].

Critics, including researchers studying human longevity genetics, caution that centenarian IGF-1 pathway variants are population-specific findings (documented mainly in Ashkenazi Jewish cohorts) and may not generalize as a universal target, and that aggressive caloric restriction in already-lean individuals risks bone density loss and reduced muscle mass, trade-offs that outweigh theoretical longevity benefit for many people [2]. The 2023 hallmarks-of-aging update retains deregulated nutrient-sensing as one of its core mechanistic hallmarks, grouping IIS, mTOR, AMPK, and sirtuin signaling together precisely because they share this common upstream logic of sensing abundance versus scarcity [5]. The Ecuadorian growth-hormone-receptor-deficiency cohort referenced above for insulin/IGF-1 signaling remains one of the few direct human genetic natural experiments in this space, and its near-absence of diabetes and reduced cancer incidence over decades of follow-up is frequently cited as the strongest available human evidence that lifelong nutrient-sensing pathway suppression can be protective [6].

The plain takeaway: dialing down nutrient-sensing pathways extends lifespan with remarkable consistency in short-lived model organisms, but the translation to safe, effective human protocols beyond moderate caloric restriction remains unproven.